Keros Therapeutics Stock Market Value
| KROS Stock | USD 53.84 0.30 0.55% |
| Symbol | Keros |
Keros Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Keros Therapeutics. If investors know Keros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Keros Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.22) | Revenue Per Share 0.019 | Quarterly Revenue Growth 47.5 | Return On Assets (0.28) | Return On Equity (0.44) |
The market value of Keros Therapeutics is measured differently than its book value, which is the value of Keros that is recorded on the company's balance sheet. Investors also form their own opinion of Keros Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Keros Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Keros Therapeutics' market value can be influenced by many factors that don't directly affect Keros Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Keros Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Keros Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Keros Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Keros Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Keros Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Keros Therapeutics.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Keros Therapeutics on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Keros Therapeutics or generate 0.0% return on investment in Keros Therapeutics over 30 days. Keros Therapeutics is related to or competes with Ideaya Biosciences, AnaptysBio, MeiraGTx Holdings, Janux Therapeutics, Fennec Pharmaceuticals, Edgewise Therapeutics, and Harmony Biosciences. Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commerc... More
Keros Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Keros Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Keros Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.54 | |||
| Information Ratio | 0.0489 | |||
| Maximum Drawdown | 16.94 | |||
| Value At Risk | (4.61) | |||
| Potential Upside | 4.39 |
Keros Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Keros Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Keros Therapeutics' standard deviation. In reality, there are many statistical measures that can use Keros Therapeutics historical prices to predict the future Keros Therapeutics' volatility.| Risk Adjusted Performance | 0.0744 | |||
| Jensen Alpha | 0.0954 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0537 | |||
| Treynor Ratio | 0.167 |
Keros Therapeutics Backtested Returns
Keros Therapeutics appears to be very steady, given 3 months investment horizon. Keros Therapeutics has Sharpe Ratio of 0.11, which conveys that the firm had a 0.11% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Keros Therapeutics, which you can use to evaluate the volatility of the firm. Please exercise Keros Therapeutics' Downside Deviation of 2.54, risk adjusted performance of 0.0744, and Mean Deviation of 2.08 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Keros Therapeutics holds a performance score of 8. The company secures a Beta (Market Risk) of 1.41, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Keros Therapeutics will likely underperform. Please check Keros Therapeutics' potential upside, as well as the relationship between the accumulation distribution and price action indicator , to make a quick decision on whether Keros Therapeutics' current price movements will revert.
Auto-correlation | -0.49 |
Modest reverse predictability
Keros Therapeutics has modest reverse predictability. Overlapping area represents the amount of predictability between Keros Therapeutics time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Keros Therapeutics price movement. The serial correlation of -0.49 indicates that about 49.0% of current Keros Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.49 | |
| Spearman Rank Test | -0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 34.29 |
Keros Therapeutics lagged returns against current returns
Autocorrelation, which is Keros Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Keros Therapeutics' stock expected returns. We can calculate the autocorrelation of Keros Therapeutics returns to help us make a trade decision. For example, suppose you find that Keros Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Keros Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Keros Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Keros Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Keros Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Keros Therapeutics Lagged Returns
When evaluating Keros Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Keros Therapeutics stock have on its future price. Keros Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Keros Therapeutics autocorrelation shows the relationship between Keros Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Keros Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Keros Stock Analysis
When running Keros Therapeutics' price analysis, check to measure Keros Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros Therapeutics is operating at the current time. Most of Keros Therapeutics' value examination focuses on studying past and present price action to predict the probability of Keros Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros Therapeutics' price. Additionally, you may evaluate how the addition of Keros Therapeutics to your portfolios can decrease your overall portfolio volatility.